Sangamo Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Sangamo Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Sangamo Therapeutics Inc Strategy Report
- Understand Sangamo Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Sangamo Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sangamo Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
H. Stewart Parker
Chairman Executive BoardMs. H. Stewart Parker has been the Chairman of the company since June 2017. Ms. Parker joined Sangamo as a Director in June 2014. From 2011 to 2013, she served as the Chief Executive Officer of the Infectious Disease Research Institute (IDRI). Prior to this, Ms. Parker founded Targeted Genetics Corporation in 1992 and served various roles in the company including the President, Chief Executive Officer and Director until 2008. From 1991 to 1993, she served at Receptech Corporation as the President and Director. Previously, Ms. Parker served as the Director at BIO a biotechnology company. Currently, she serves as member of board of Directors of different companies including IDRI, Oncogenex technologies and C3 Jian Inc.
Sandy Macrae, Ph.D.
Chief Executive Officer; Director; President Executive BoardDr. Sandy Macrae has been the President, Chief Executive Officer and Director of the company since June 2016. He also serves on the board of directors of 4D Pharma plc. Prior to this role, Mr. Macrae served as the Global Medical Officer of Takeda Pharmaceuticals, from 2012 to March 2016. From 2009 to 2012, he served at GlaxoSmithKline (GSK) as the Senior Vice President, Emerging Markets Research and Development (R&D). From 2007 to 2008, Mr. Macrae also served as the Vice President, Business Development at GSK. Previously, he worked for SmithKline Beecham.
Prathyusha Duraibabu
Chief Financial Officer Senior ManagementMs. Prathyusha Duraibabu has been the Chief Financial Officer of the company since 2021. Prior to this, she served as the Corporate Controller at Pacific Biosciences of California, Inc.
Mark McClung
Executive Vice President; Chief Operating Officer Senior ManagementMr. Mark McClung has been the Executive Vice President and Chief Operating Officer of the company since 2021. Previously, he served as the Chief Business Officer of the company since 2020. Prior to this, he served as General Manager of Global Oncology Commercial at Amgen. Previously, Mr. McClung served at GlaxoSmithKline as Head of Global Commercial for GSK Oncology.
Whitney Jones
Senior Vice President; Chief People Officer Senior ManagementMr. Whitney Jones has been the Chief People Officer and Senior Vice President of Sangamo Therapeutics Inc since 2020. Prior to this, he served as the Chief People Officer at LendingClub. Before that he served as the Global Head of Human Resources at Grifols.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer